Carl Atkinson to Heart Transplantation
This is a "connection" page, showing publications Carl Atkinson has written about Heart Transplantation.
Connection Strength
2.776
-
Surgical Innovation: Heart Transplantation After Cardiac Death. Surg Innov. 2021 Oct; 28(5):656-658.
Score: 0.578
-
Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury. Circulation. 2015 Mar 31; 131(13):1171-80.
Score: 0.386
-
Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts. Circulation. 2013 Mar 26; 127(12):1290-9.
Score: 0.336
-
Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation. J Immunol. 2010 Dec 01; 185(11):7007-13.
Score: 0.286
-
Complement-dependent inflammation and injury in a murine model of brain dead donor hearts. Circ Res. 2009 Nov 20; 105(11):1094-101.
Score: 0.266
-
Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. J Heart Lung Transplant. 2005 May; 24(5):551-8.
Score: 0.196
-
Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant. 2004 Apr; 23(4):427-35.
Score: 0.181
-
Modulating donor mitochondrial fusion/fission delivers immunoprotective effects in cardiac transplantation. Am J Transplant. 2022 02; 22(2):386-401.
Score: 0.154
-
Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope. J Heart Lung Transplant. 2021 10; 40(10):1112-1121.
Score: 0.150
-
Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy. J Heart Lung Transplant. 2010 Apr; 29(4):417-23.
Score: 0.068
-
Endothelial activation in the transplanted human heart from organ retrieval to 3 months after transplantation: an observational study. J Heart Lung Transplant. 2005 May; 24(5):593-601.
Score: 0.049
-
Heat shock protein, inducible nitric oxide synthase and apoptotic markers in the acute phase of human cardiac transplantation. Eur J Cardiothorac Surg. 2003 Dec; 24(6):932-9.
Score: 0.044
-
The energy metabolism in the right and left ventricles of human donor hearts across transplantation. Eur J Cardiothorac Surg. 2003 Apr; 23(4):503-12.
Score: 0.042
-
Histopathology of cardiac xenograft rejection in the pig-to-baboon model. J Heart Lung Transplant. 2002 Apr; 21(4):474-84.
Score: 0.039